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Purpose: To investigate the presence of epithelial sodium channels (ENaC) in rabbit and human conjunctival epithelium
and to test the effects of topical amiloride, a potassium-sparing diuretic that blocks the ENaC, on tear quantity in rabbits.
Methods: Both healthy normal human and rabbit conjunctival tissues underwent immunohistochemistry staining for
ENaC-α and γ subunits as well as for reverse transcription polymerase chain reaction (RT-PCR) for detection of ENaC-
α and ENaC-γ subunit mRNA expression. Rabbits were instilled topical amiloride eye drops and tear function tests were
performed before and after instillations.
Results: Immunohistochemical staining for ENaC-α subunit in all rabbit eyes showed positive staining in apical and basal
conjunctival epithelial cells. Human conjunctival epithelia revealed positive staining with ENaC-α antibody especially in
the apical and basal layers. Immunohistochemistry staining with ENaC- γ antibody also revealed positive staining of the
conjunctival epithelial cells especially in the basal layers. The ENaC-α mRNA was detected in samples from healthy white
rabbit conjunctival epithelia, and ENaC-α and ENaC- γ mRNAs were detected in samples from healthy human conjunctival
epithelia. The mean tear quantity showed a significant increase at 15 and 30 min compared to the pre-instillation value in
eyes assigned to amiloride eye drops. The mean tear quantity at 15 and 30 min was significantly higher in the amiloride
group compared to the control eyes.
Conclusions: Topical amiloride application appears to increase the quantity of preocular tears owing to inhibition of
conjunctival epithelial sodium channels.
It  is  well  known  that  the  epithelial  sodium  channels
(ENaC)  exist  in  many  tissues  throughout  the  body;  such
channels  have  been  characterized  in  amphibian  skin  and
urinary bladder, renal collecting duct, distal colon, sweat, and
salivary glands, lung, and taste buds. These channels mediate
the first step of active Na+ reabsorption and play a major role
in the maintenance of electrolyte and water homeostasis in all
vertebrates [1].
In human ocular tissues, ionic transport has been reported
to exist in the corneal endothelium [2] as well as the ciliary
body [3], and retinal pigment epithelium [4]. Ionic transport
through these tissues is reported to provide the driving force
for fluid secretion, a function necessary for the control and
maintenance  of  corneal  [5]  and  lens  transparency  [6],
intraocular pressure [7], and retinal structure [8]. The mucin
secreting stratified conjunctival epithelium covers the inner
eyelid  and  bulbar  ocular  surfaces.  Ionic  transport  by  the
conjunctival epithelial cells may be important in determining
the amount of tears collected in the conjunctival sac which
may also affect the stability of the tear film. Although the
composition, biochemistry and physiologic aspects of the tear
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film have been well studied [9-17], the presence and role of
sodium channels in human and rabbit conjunctival epithelia
and the role of pharmacologically controlled fluid secretion
dynamics of the tear film has not been fully investigated and
elucidated until now. It is known that the ENaCs are involved
with the water resorption in the kidney and that amiloride
blocks the ENaC and suppresses the water resorption causing
its retention [1].
We initially investigated the presence of ENaC in rabbit
and  human  conjunctival  epithelium  by  performing
immunohistochemistry  staining  and  reverse  transcription
polymerase  chain  reaction  (RT–PCR)  for  ENaC  mRNA
expression  for  the  first  time  in  the  literature.  We  also
performed animal experiments in rabbits by instilling topical
amiloride eye drops to investigate the timewise effects of
topical application on tear quantity and to test the feasibility
of topical amiloride application as a possible future treatment
modality for dry eyes.
METHODS
Seven female Japanese white rabbits (3 kg bodyweight) were
obtained from the Shiraishi Experimental Animal Breeding
Farm, Tokyo, Japan. One rabbit was anesthetized with 4 ml
of intramuscular ketamine and xylazine (1:7 mixture) and
topical xylocaine, and conjunctival tissue was excised. All
rabbits were handled in strict accordance with the Association
for Research in Vision Ophthalmology Statement on the Use
Molecular Vision 2010; 16:2279-2285 <http://www.molvis.org/molvis/v16/a244>
Received 25 June 2010 | Accepted 29 October 2010 | Published 4 November 2010
© 2010 Molecular Vision
2279of  Animals  in  Ophthalmic  and  Vision  Research.  Normal
human conjunctival tissues were obtained from the free flap
site  during  pterygium  surgery,  and  informed  consent  was
obtained  from  all  participants.  Both  human  and  rabbit
conjunctival  tissues  underwent  immunohistochemistry
staining for ENaC-α and γ subunits as well as processing for
RT–PCR for detection of ENaC-α and ENaC-γ subunit mRNA
expression. Six rabbits were instilled with topical amiloride
eye drops and tear function tests were performed before and
after instillations.
Immunohistochemistry: Rabbit and human conjunctival
tissues were fixed in 4% paraformaldehyde and dehydrated in
ascending grades of alcohol (70%, 80%, 90%, 95%, and 99%:
each step once for 1 h, with the last stage in 99% alcohol for
3 h). The samples were then treated in xylene and embedded
in paraffin, and 5 μm sections were cut. The sections were
treated with xylene three times for 15 min and then treated
with 99% ethanol three times for 10 min each. The sections
were incubated with 0.3% H2O2 in methanol for 1 h at room
temperature to deactivate internal peroxidase. The step was
followed  by  rehydration  in  descending  grades  of  alcohol.
Then sections were treated with 1% BSA/0.2% gelatin/0.05%
saponin/PBS  (pH  7.4)  three  times  to  block  nonspecific
signals, and were incubated with primary antibodies overnight
at 40 °C. The primary antibodies were goat polyclonal anti-
human ENaCs (sc-22239: for ENaC-α, sc-22242: for ENaC-
β, and sc-22245: for ENaC-γ; Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA). The working dilution factors with PBS were
1:2 for rabbit tissue, 1:500 for human ENaC-α, 1:100 for
human ENaC-β, and 1:2,500 for human ENaC-γ. Following
overnight incubation with primary antibodies, the sections
were washed with 0.1% BSA/0.2% gelatin/0.05% saponin/
PBS (pH 7.4) three times for 5 min each. Rabbit sections were
incubated with Rabbit anti-goat IgG FITC conjugated (F7367;
Sigma-Aldrich, St. Louis, MO) diluted 1:50 with PBS for 1 h,
then washed three times with PBS. Propidium iodide (1 μg/
ml) was used for nucleus staining.
After mounting with Vectorshield (Vector Laboratories,
Inc.,  Burlingame,  CA),  pictures  were  obtained  with
photoimaging  system  (BX50  and  DP70;  Olympus  Corp.,
Tokyo, Japan). Human sections were incubated with mouse
anti-goat IgG peroxidase conjugated (A9452; Sigma-Aldrich)
diluted 1:200 with PBS. Enzymatic staining was performed
with 0.2 mg/ml DAB/0.03% H2O2/Tris-Cl (pH7.5) solution
for 10 min followed by counter staining with hematoxylin.
Sections  were  then  treated  with  graded  alcohol,  xylene,
mounted with Eukitt (Sigma-Aldrich) and examined under
light  microscope.  Primary  antibodies  were  excluded  in
experiments for negative controls.
RT–PCR for ENaC mRNA expression: Total RNA was
isolated using RNeasy mini Kit (Qiagen, Inc., Valencia, CA)
from 30 mg of homogenized tissues. RNA concentration was
quantified  by  spectrophotometry  (Amersham  Biosciences
AB, Uppsala, Sweden). Two sets of oligonucleotide primers
(Thermo Electron Corp., Waltham, MA) were synthesized for
RT–PCR analysis as follows: Sense and antisense primers for
ENaC-α for rabbits were 5′-GAC CTG GAC AGC ATC ACC
CAG CAG ACG-3′ and 5′-GCA GCG GGA TGA AGT CAT
TCT GCT CTG-3′, for ENaC-α for human samples these were
5′-TGG ACT GGA AGG ACT GGA AGA-3′ and 5′-CGG
CAG  GCG  AAG  ATG  AA-3′,  respectively.  Sense  and
antisense primers for beta-actin (ACTB) for the rabbit study
were 5′-CAA CCG TGA AAA GAT GAC CC-3′ and 5′-CGA
TGC CAC AGG ATT CCA TA-3′, and for the human study
these were 5′-CGT TGA CAT CCG TAA AGA CCT C-3′ and
5′-GTA CTC CTG CTT GCT GAT CCA C-3′ for the control
experiments. The sizes of RT–PCR products were 574 bp for
ENaC-α for the rabbit and 199 bp for ENaC-α for the human
study. RT–PCR product sizes were 484 bp for ACTB for the
rabbit study and 229 bp for ACTB for the human study.
The RT–PCR reactions were performed using one-step
RT–PCR kit (Qiagen). The amplification program was as
follows: 50 °C, 30 min; for reverse transcription, 95 °C, 15
min; for initial Taq enzyme activation, following PCR cycle
94 °C, 30 s; denaturation, 60 °C, 30 s; annealing, 72 °C, 60 s;
extension. Five µl of product were run on 3% agarose gel to
confirm  sizes  of  PCR  products.  Optimization  for
concentration,  amplification  efficiency,  faithful
coamplification with housekeeper gene primer and prone sets
(glyceraldehyde-3-phosphate  dehydrogenase  [GAPDH])
were also performed.
Topical  amiloride  eye  drop  application  experiments:
Amiloride eye drops (0.1%) were prepared by dilution of
commercially  available  powder  (Wako  Pure  Chemical
Industries, Ltd., Osaka, Japan) with sterile saline solution.
Five right rabbit eyes were allocated to amiloride drops, and
the left eyes to sterile saline drops. Schirmer test with 10 μl of
0.4%  oxybuprocaine  topical  anesthesia  was  performed  by
inserting  standard  strips  (Alcon  Laboratories,  Inc.,  Fort
Worth, TX) in the lower conjunctival sac for 5 min before as
well as 5 min, 15 min, 30 min, and 60 min after amiloride eye
drop application. Fifty μl of amiloride eye drops were instilled
into the lower conjunctival sac by a micropipette to the right
eyes and 50 μl of sterile saline was instilled to the left eyes at
the beginning of the experiments.
Rabbit conjunctival tissues were excised after amiloride
drop  application,  stained  with  hematoxylin-eosin  and
examined  under  light  microscopy  to  investigate  any
morphological alterations due to eye drop application.
Corneal fluorescein staining: Two μl of 1% fluorescein
solution  were  applied  by  micropipette  before  amiloride
application and at 60 min after to check the effects of the
topical amiloride application on the corneal epithelium. The
fluorescein  staining  was  scored  according  to  the  protocol
described by Shimmura et al. [18-20]. Briefly, the cornea was
divided into three equal areas of upper, middle and inferior
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scale  of  0  (no  staining)  to  3  points  (intense  staining).  A
fluorescein  staining  score  above  1  point  was  considered
abnormal (maximum: 9 points). The cornea was inspected
with  a  hand  held  slit  lamp  microscopy  (Carl  Zeiss  AG,
Oberkochen, Germany).
RESULTS
Immunohistochemical  confirmation  of  ENaC-α,  β,  and  γ
subunits  in  rabbit  conjunctiva:  Immunohistochemical
staining  for  ENaC-α,  β,  and  γ  subunits  in  all  rabbit  eyes
showed  positive  staining  in  apical  and  basal  conjunctival
epithelial cells as well as in inner medullas of kidney for
positive control as shown in Figure 1.
RT–PCR for ENaC-α mRNA expression in rabbit conjunctiva:
To assess the expression of ENaC-α in rabbit conjunctival
epithelial cells, RT–PCR technique using primer for ENaC-
α was adopted. MRNA of ENaC-α was detected in samples
from healthy white rabbit conjunctival epithelia (Figure 2).
Because mRNAs of the same samples from experimentally
manipulated  conjunctiva  were  amplified  by  primers  of
ATCB (Figure 2), we verified that these samples were suitable
for detection of the mRNA of interest.
Immunohistochemical confirmation of ENaC-α and ENaC-γ
subunits  in  human  conjunctiva:  Human  conjunctival
epithelium revealed positive staining with ENaC-α antibody
especially  in  the  apical  and  basal  layers  (Figure  3A).
Immunohistochemistry staining with ENaC-γ antibody also
revealed positive staining of the conjunctival epithelial cells
especially in the basal layers with some staining in the apical
layers (Figure 3B). Isotype control specimens did not reveal
any staining with the relevant antibodies. A representative
isotype control specimen for human conjunctival ENaC-α
immunohistochemical staining is shown in Figure 3C.
RT–PCR for ENaC-α and ENaC-γ mRNA expression in human
conjunctiva: To assess the expression of ENaC-α and ENaC-
Figure 1. Expression of ENaC subunits in rabbit conjunctiva in immunohistochemical stainnings.   ENaC-α ( A and I), ENaC-β (B and J),
and ENaC-γ (C and K) were positive at apical layer of conjunctiva. As a positive control, ENaC-α (E and M), ENaC-β (F and N), and ENaC-
γ (G and O) were positive at inner medullas of kidney. Isotype control specimen showed no positive staining in conjunctiva (D and L) and
kidney (H and P). Scale bars in A-H represent 20 µm, and scale bars in I-P represent 40 µm.
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using primers for ENaC-α and ENaC- γ was adopted. MRNA
of ENaC-α and ENaC- γ was detected in samples from healthy
human conjunctival epithelia obtained from part of the flap
site from surgery for pterygium (Figure 4). Because mRNAs
of  the  same  samples  from  experimentally  manipulated
conjunctiva were amplified by primers of GAPDH (Figure 4,
lower band), we verified that these samples were suitable for
detection of the mRNA of interest.
The change of Schirmer test value with topical amiloride eye
drops: The mean tear quantity showed a significant increase
at 15 and 30 min compared to the pre-instillation value in eyes
assigned to amiloride eye drops. The mean tear quantity at 15
and 30 min was significantly higher in the amiloride group
compared to control eyes (Figure 5).
Slit lamp examination and fluorescein staining:  Slit lamp
examinations  did  not  show  any  conjunctival  and  corneal
injection, edema, or sign of inflammation before and after eye
Figure  2.  Expression  of  ENaC-α  and
housekeeping  gene  (ACTB)  in  rabbit
conjunctiva.
Figure 3. Immunohistochemistry stainings of ENaC- α and ENaC-γ subunits in human conjunctiva.
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staining was not detected before or at the end of topical eye
drop instillations during the experiments. Hematoxylin-eosin
staining of rabbit conjunctival and corneal tissue specimens
at the end of amiloride eye drop instillations did not reveal any
gross morphological alterations (data not shown).
DISCUSSION
Current conventional treatment for dry eye mainly consists of
artificial tear instillations and punctum plug insertion with the
aim to increase the preocular tear volume [21-23]. Recently,
newer muscarinic or P2Y2 receptor agonists such as peroral
cevimelin [24] and diquasofol tetrasodium, which increase the
preocular   tear   quantity  by   stimulating   the  lacrimal  gland,
have  been  reported  to  be  effective  in  the  treatment of
severe   dry    eyes.  Agents  which  are  among  the
ophthalmologist’s armamentarium in the treatment of dry eye
syndrome include DE-089, and 15-S-HETE which principally
act  by  increasing  the  ocular  surface  mucin  secretion  and
improving the tear stability [25]. Because the conjunctiva is a
“fluid secreting” epithelium [26], we considered the idea of
applying topical amiloride eye drops, which we hoped would
increase  the  preocular  tear  quantity  through  inhibition  of
conjunctival epithelial sodium channels. We believed that
such  an  inhibition  would  result  in  suppression  of  the
absorption of the “existing preocular tears” by the ocular
surface epithelium, resulting in increased availability of one’s
own tear secretion to the ocular surface. Before we tested this
hypothesis,  we  performed  immunohistochemical  and  RT–
PCR  experiments  to  confirm  the  existence  of  epithelial
sodium channels in rabbit and human conjunctival tissues.
The existence of ENaC in the rat conjunctival epithelium
has  already  been  reported  [27].  Kompella  et  al.  [28,29]
confirmed  the  existence  of  sodium  epithelial  channels  in
rabbit conjunctiva with ionic transport experiments. However,
they had not performed immunohistochemistry or RT–PCR
for confirmation of the presence of ENaC. The presence of
Figure 4. Expression of CIC-2, ENaC-
α,  ENaC-γ,  and  housekeeping  gene
(ACTB) in human conjunctiva.
Figure 5. The change of Schirmer test
value  in  topical  amiloride  eye  drop
experiment.
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not been investigated by immunohistochemistry so far to our
knowledge.
In this study, we confirmed the presence of ENaC in
rabbit  and  human  conjunctival  epithelia  using  renal
epithelium  as  the  positive  control.  For  the  next  step,  we
performed topical amiloride eye drop instillations in rabbits
and investigated the timewise alterations in tear quantity. The
preocular tear quantity was observed to increase for the first
5 min, which might have, in part resulted from the instillation
of the eye drops.
Interestingly, we noted that although the preocular tear
quantity continued to increase afterward in the eyes that were
allocated  to  amiloride  eye  drops,  the  contralateral  eyes
assigned to saline drops showed a significant decrease in tear
quantity, probably due to the drainage of the preocular tears
from the lacrimal puncta. It is our belief that the significantly
higher  tear  volumes  at  15  and  30  min  may  be  due  to
accumulation  of  available  tears  at  a  level  exceeding  the
drainage of tears due to amiloride effects on the ocular surface
epithelia.
Data from Watsky et al. [30] previously suggested that
the rabbit conjunctival surface area was 9 times larger than
the corneal surface area and that the conjunctiva may play a
dominant role in regulating electrolyte and fluid balance in the
tear film. In our observations, amiloride eye drops caused a
timewise increase in tear quantity as assessed by the Schirmer
test, and the effect of amiloride eye drops on the preocular tear
quantity was maintained for 30 min which started to decline
afterward. It would be interesting to test the dose-dependent
effects of amiloride eye drops and concurrent tear electrolyte
changes  in  animal  dry  eye  models  in  future  experiments.
Whether inhibition of ENaC by amiloride which leads to
reduced absorption of tears by the conjunctival epithelium
induces  functional  consequences  on  the  conjunctival
epithelium itself or not also deserves further investigation.
Indeed,  such  inhibition  may  affect  the  intracellular  and
extracellular water ratio and result in cellular dehydration.
Further studies employing bioimpedance analyses methods to
test  the  conjunctival  cellular  hydration  with  amiloride
application would provide very interesting information [31].
Slit lamp examinations and ultrastructural observations
did not reveal corneal staining, crack lines or allergic reactions
or  any  related  morphological  alterations  in  the  light
microscope (data not shown) as adverse effects of topical
amiloride application. However, we believe that this claim
should  be  further  tested  with  electron  microscopical
observations and with more frequent instillations of amiloride
eye drops in animal models.
Safety experiments should also assess time-wise changes
in corneal endothelial ultrastructural morphology and counts,
and intraocular pressure measurements since sodium channels
exist in the pigmented ciliary body epithelium and corneal
endothelium. In summary, the preliminary findings of the
current study confirmed the presence of sodium channels in
rabbit  and  human  conjunctival  epithelia  and  that  topical
amiloride  application  may  be  increasing  the  quantity  of
preocular  tears  due  to  inhibition  of  these  channels.  The
preliminary  findings  from  this  study  justify  further
experimental research on amiloride as a possible treatment
alternative for dry eye disease.
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